The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper - Report - MDSpire
Advertisement
The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper
By
Stamatis Karakonstantis
Theodore Lytras
Siran Keske
Sotirios Tsiodras
Lea Papst
Petros Ioannou
Petar Velikov
Linn Persson Berg
Giulia De Angelis
Virginie Prendki
Cornelia Adlhoch
Pasi Penttinen
Jordi Rello
Gaetan Gavazzi
Subhi Malhotra-Kumar
Chrysanthi Skevaki
Michele Slafkosky
Barbara Rath
on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV) and Study Group for Infections in the Elderly (ESGIE)
Clinical Report: Evolving Patient Care Strategies for Influenza Post-COVID-19
Overview
This position paper highlights the need to center patient care from initial influenza-like illness symptoms through recovery in the post-COVID-19 era. It identifies current care deficiencies such as delayed healthcare access, fragmented care, and poor follow-up, proposing strategies to improve diagnosis, management, and continuity of care for influenza and other respiratory viral infections.
Background
The COVID-19 pandemic initially reduced attention to seasonal influenza due to nonpharmaceutical interventions and behavioral changes. As these measures relax, influenza and other respiratory viruses have resurged, often co-circulating with COVID-19, creating challenges for healthcare systems. This necessitates revised patient-centered care strategies that address timely diagnosis, treatment, and follow-up. The expert panel mapped the patient journey to identify critical decision points and gaps in care to inform future guidelines.
Data Highlights
The article is a narrative review and position statement without numerical data tables but emphasizes qualitative findings from patient journey mapping and expert consensus to improve influenza care pathways.
Key Findings
Influenza and other respiratory viral infections have rebounded post-pandemic, often co-circulating with COVID-19, complicating diagnosis and management.
Current care pathways suffer from delayed access to healthcare, fragmented services, and inadequate follow-up instructions, impacting patient outcomes.
Patient journey mapping identified critical clinical decision points from symptom onset to recovery, highlighting areas needing consensus and research.
Recommendations include optimizing initial patient contact settings (primary care, emergency, telehealth), refining diagnostic strategies (test-and-treat vs empirical), and improving antiviral use guidance.
Follow-up procedures and discharge instructions require standardization to ensure continuity of care and better recovery monitoring.
Future guidelines and research should focus on enhancing timely access, integrated care, and patient-centered management in the postpandemic context.
Clinical Implications
Clinicians should adopt a patient-centered approach starting at the first signs of influenza-like illness, ensuring timely evaluation and appropriate diagnostic testing to guide antiviral therapy. Integration of care pathways and clear follow-up instructions are essential to improve outcomes and reduce healthcare fragmentation. Telehealth and other innovative access points may help manage patient flow during peak respiratory virus seasons.
Conclusion
The evolving landscape of respiratory viral infections post-COVID-19 demands renewed focus on patient-centered care pathways for influenza. Addressing identified care gaps through improved access, diagnostics, treatment, and follow-up will enhance patient outcomes and healthcare system resilience.
References
ESCMID Position Paper 2025 -- Evolving Patient Care Strategies for Influenza in the Aftermath of the COVID-19 Pandemic
by Stamatis Karakonstantis, Theodore Lytras, Siran Keske, Sotirios Tsiodras, Lea Papst, Petros Ioannou, Petar Velikov, Linn Persson Berg, Giulia De Angelis, Virginie Prendki, Cornelia Adlhoch, Pasi Penttinen, Jordi Rello, Gaetan Gavazzi, Subhi Malhotra-Kumar, Chrysanthi Skevaki, Michele Slafkosky, Barbara Rath, on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV) and Study Group for Infections in the Elderly (ESGIE)